Envoy Medical (COCH) Income from Continuing Operations (2021 - 2026)
Envoy Medical (COCH) posted Income from Continuing Operations of 6223000.0 for Q1 2026, up 2.54% sequentially from 6385000.0 in Q4 2025, and down 11.09% YoY from 6998844.81 in Q1 2025.
Envoy Medical (COCH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Envoy Medical has reported Income from Continuing Operations for 6 years, with the latest figure at 6223000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 11.09% year-over-year to 6223000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24481000.0 (up 98.75% YoY) and the FY2025 annual result came in at 23860000.0, up 1.45% from the prior year.
- Income from Continuing Operations rose to 6223000.0 in Q1 2026 per COCH's latest filing, from 6385000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 12461381.0 in Q1 2022 and troughed at 1855634000.0 in Q3 2024.
- A 5-year average of 116370519.59 and a median of 4984000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations soared 1400.18% in 2022, then slumped 45325.56% in 2024.
- Over 5 years, Income from Continuing Operations stood at 2008739.0 in 2022, then slumped by 150.9% to 5040000.0 in 2023, then increased by 2.12% to 4933000.0 in 2024, then dropped by 29.43% to 6385000.0 in 2025, then gained by 2.54% to 6223000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 6223000.0, 6385000.0, and 6179000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Envoy Medical | 76.96 Mn | 57.28 Mn | -227,000.00 | -5.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.82 Mn |
| Mar 31, 2026 | -6.22 Mn |
| Dec 31, 2025 | -6.39 Mn |
| Sep 30, 2025 | -6.18 Mn |
| Jun 30, 2025 | -5.69 Mn |
| Mar 31, 2025 | -5.60 Mn |
| Dec 31, 2024 | -4.93 Mn |
| Sep 30, 2024 | -1.86 Bn |
| Jun 30, 2024 | -92.35 Mn |
| Mar 31, 2024 | -4.98 Mn |
| Dec 31, 2023 | -5.04 Mn |
| Sep 30, 2023 | -4.09 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | 717,701.00 |
| Dec 31, 2022 | -2.01 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 12.46 Mn |
| Dec 31, 2021 | -4.72 Mn |
| Sep 30, 2021 | 5.57 Mn |